ACORN CAPITAL ADVISORS, LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$185.0B
Holdings
20
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (20 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CGONCG ONCOLOGY INC | 1,131,501 | $32.5B | 17.54% | |
| 2 | YMABUSDY-MABS THERAPEUTICS INC | 2,861,825 | $22.4B | 12.11% | |
| 3 | CADLCANDEL THERAPEUTICS INC | 1,939,644 | $16.8B | 9.10% | |
| 4 | URGNUROGEN PHARMA LTD | 1,516,303 | $16.1B | 8.73% | |
| 5 | PBYIPUMA BIOTECHNOLOGY INC | 2,450,711 | $12.0B | 6.49% | |
| 6 | BCAXBICARA THERAPEUTICS | 643,381 | $11.2B | 6.06% | |
| 7 | TERNTERNS PHARMACEUTICALS INC | 1,971,264 | $10.9B | 5.90% | |
| 8 | OKURONKURE THERAPEUTICS INC | 1,439,674 | $10.2B | 5.54% | |
| 9 | TRVITREVI THERAPEUTICS INC | 2,001,048 | $8.2B | 4.46% | |
| 10 | TARAPROTARA THERAPEUTICS INC | 1,279,800 | $6.8B | 3.65% | |
| 11 | HELPCYBIN INC | 734,393 | $6.5B | 3.50% | |
| 12 | CRDFCARDIF ONCOLOGY INC | 1,442,308 | $6.3B | 3.38% | |
| 13 | ASNSUSDX4 PHARMACEUTICALS INC | 7,310,650 | $5.4B | 2.90% | |
| 14 | —MURAL ONCOLOGY PLC | 1,286,079 | $4.1B | 2.24% | |
| 15 | WHWKAADI BIOSCIENCE INC | 1,147,052 | $3.6B | 1.96% | |
| 16 | 0OPOPTINOSE INC | 422,813 | $2.8B | 1.53% | |
| 17 | QTTBQ32 BIO INC. | 803,425 | $2.8B | 1.49% | |
| 18 | ACRVACRIVON THERAPEUTICS INC | 405,237 | $2.4B | 1.32% | |
| 19 | BCABBIOATLA INC | 4,032,046 | $2.4B | 1.29% | |
| 20 | VYNEVYNE THERAPEUTICS INC | 456,970 | $1.5B | 0.83% |